Skip to main content
NCBI home page
Indian Journal of Clinical Biochemistry logoLink to Indian Journal of Clinical Biochemistry
. 2006 Mar;21(1):131–136. doi: 10.1007/BF02913081

Effect of supplementation of vitamin E, vitamin C and reduced glutathione on copper ion induced lipoprotein oxidation in renal diseased patients—Anin vitro study

C S Parameswari 1,✉, B Vijayageetha 1, R Vijayakumar 2
PMCID: PMC3453764  PMID: 23105584

Abstract

The oxidative modification of lipoprotein especially low density lipoprotein (LDL) plays a key role in the initiation and progression of atherosclerosis. Serum apolipoproteinB (apoB) level is found to be an important marker for atherosclerosis. The present paper focuses on the measurement of serum apoB levels and the effect of Vitamin E, Vitamin C and reduced glutathione on the copper ion induced oxidation of LDL + VLDL (VLDL-Very Low Density Lipoprotein) lipoprotein fraction isolated from the serum of chronic renal failure (CRF) and renal transplanted patients. The level of apoB is significantly higher in the serum of transplanted patients when compared to CRF patients and normal subjects. The level of TBARS formed in oxidized LDL + VLDL lipoprotein fraction of CRF and renal transplanted patients are significantly increased than normal even in the presence of antioxidants but the level of TBARS produced, with antioxidants is comparatively lesser than that produced by oxidized lipoprotein fraction without antioxidants. It may be concluded than that produced by oxidized lipoprotein fraction without antioxidants. It may be concluded that oxidation of LDL can be prevented at an earlier stage by Vitamin E supplementation. The supplementation with Glutathione serves as the best method of preventing the lipoprotein oxidation among the renal diseased patients.

Keywords: Lipoprotein oxidation, antioxidants, renal transplantation, lipid peroxidation and apolipoprotein B

Full Text

The Full Text of this article is available as a PDF (106.5 KB).

References

  • 1.Diaz J.M., Sainz Z., Guirado L.L., Ortiz-Herbener F., Picazo M., Garcio-Camin R., Palou J., Alcaraz A., Sola R. Risk factors for cardiovascular disease after renal transplantation. Transplant Proc. 2003;35(5):1722–1724. doi: 10.1016/S0041-1345(03)00567-0. [DOI] [PubMed] [Google Scholar]
  • 2.Greaves S.C., Sharpe D.N. Cardiovascular disease in patients with end stage renal failure Aust. NZJ. Med. 1991;22:152–159. doi: 10.1111/j.1445-5994.1992.tb02797.x. [DOI] [PubMed] [Google Scholar]
  • 3.Rostand S.G., Brunzell J.D., Cannon R.O., Victor R.G. Cardiovascular complications in renal failure. J. Am. Soc. Nephrol. 1991;2:1053–1061. doi: 10.1681/ASN.V261053. [DOI] [PubMed] [Google Scholar]
  • 4.Ma K.W., Greene E.L., Raij L. Cardiovascular risk factors in Chronic renal failure and hemodialysis populations. Am. J. Kidney Dis. 1992;19:505–513. doi: 10.1016/s0272-6386(12)80827-4. [DOI] [PubMed] [Google Scholar]
  • 5.Wolfe R.A., Ashby V.B., Milford E.L., Ojo A.O., Ettenger R.E., Agodoa L.Y.C., Held P.J., Port F.K. Comparison of mortality in all patients on dialysis awaiting transplantation and recipients of a first cadaveric transplant. N. Engl. J. Med. 1998;341:1725–1730. doi: 10.1056/NEJM199912023412303. [DOI] [PubMed] [Google Scholar]
  • 6.Parfrey P.S., Foley R.N., Rigatto C. Risk issues in renal transplantation: Cardia aspects. Transplant Proc. 1999;31:91–91. doi: 10.1016/S0041-1345(98)01631-5. [DOI] [PubMed] [Google Scholar]
  • 7.Knott H.M., Anna Baoutina, Michael J.D., Roger T.D. Comparative time-courses of copper ion mediated protein and lipid oxidation in low density lipoprotein. Arch. Biochem. Biophys. 2002;400:223–232. doi: 10.1016/S0003-9861(02)00018-8. [DOI] [PubMed] [Google Scholar]
  • 8.Mark J., Burkitt A critical overview of the chemistry of Copper-dependent low density lipoprotein oxidation: roles of lipid hydroperoxide, α-tocopherol, thiols and ceruloplasmin. Arch Biochem. Biophys. 2001;394(1):117–135. doi: 10.1006/abbi.2001.2509. [DOI] [PubMed] [Google Scholar]
  • 9.Gieseg S.P., Esterbauer H. Low density lipoprotein is saturable, by pro-oxidant copper. FEBS Lett. 1994;343:188–194. doi: 10.1016/0014-5793(94)80553-9. [DOI] [PubMed] [Google Scholar]
  • 10.Erin L.M., Roger T.D., Keith K.S., Wendy J. Apolipoprotein B of oxidised LDL accumulates in the lysosomes of macrophages. Biochim. Biophys. Acta. 1994;1212:80–92. doi: 10.1016/0005-2760(94)90192-9. [DOI] [PubMed] [Google Scholar]
  • 11.Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherogenesis Free Radic. Biol. Med. 1996;20:707–727. doi: 10.1016/0891-5849(95)02173-6. [DOI] [PubMed] [Google Scholar]
  • 12.Rusell Ross. Mechanisms of disease. NEJM. 1999;340(2):115–126. doi: 10.1056/NEJM199901143400207. [DOI] [PubMed] [Google Scholar]
  • 13.Maciejko J.J., Stanley S.L., Lois Markyvehc, Michael P.S., Roger D.B. New assay of apolipoprotein A-1 and B by Rate Nephelometry evaluated. Clin. Chem. 1987;33(11):2065–2069. [PubMed] [Google Scholar]
  • 14.Burstein M., Scholnick H.R. Lipoprotein-polyanion metal interactions. Adv. Lipid. Res. 1973;11:68–108. [PubMed] [Google Scholar]
  • 15.Markwell M.A.S., Haas S.M., Bieber Z.L., Tolbert N.E. A modification of Lowry procedure to simplify protein determination in membrane and lipoprotein sample. Anal. Biochem. 1978;87:206–210. doi: 10.1016/0003-2697(78)90586-9. [DOI] [PubMed] [Google Scholar]
  • 16.Wallin B., Rosengren B., Shetzer H.G., Comejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reactive substance formation in a single microtitre plate: Its use for evaluation of antioxidants. Anal. Biochem. 1993;208:10–15. doi: 10.1006/abio.1993.1002. [DOI] [PubMed] [Google Scholar]
  • 17.Young S.G. Recent progress in understanding apolipoproteinB. Circulation. 1989;80:219–233. doi: 10.1161/01.cir.82.5.1574. [DOI] [PubMed] [Google Scholar]
  • 18.Averna M.R., Barbagallo C.M., Sparacino V., Carputo F., Marcino C., Calabrese S., Notarbartolo A. Follow-up of lipid and apoprotein levels in renal transplant recipients. Nephron. 1991;58:225–256. doi: 10.1159/000186432. [DOI] [PubMed] [Google Scholar]
  • 19.Kasiske B.L. Risk factors for accelerated atherosclerosis in renal transplant recipients. Am. J. Med. 1988;84(6):985–992. doi: 10.1016/0002-9343(88)90302-6. [DOI] [PubMed] [Google Scholar]
  • 20.Attman Per Ola, Alanpovic Peter. Lipid and apolipoprotein profiles of Uremic dyslipoproteinemia: Relation to renal function and dialysis. Nephron. 1991;57:401–410. doi: 10.1159/000186303. [DOI] [PubMed] [Google Scholar]
  • 21.Eneny J., Loughrey C.M., Trimble E.R., McNamee P.T., Young I.S. Susceptibility of VLDL to oxidation in patients on regular hemodialysis. Atherosclerosis. 1997;129(2):215–220. doi: 10.1016/S0021-9150(96)06019-4. [DOI] [PubMed] [Google Scholar]
  • 22.Paul J.L., Sall N.D., Soni T., Poginet J.L., Lindenbaum A., Man N.K., Moatti N., Raichvarg D. Lipid peroxidation abnormalities in hemodialysis patients. Nephron. 1993;64:106–106. doi: 10.1159/000187287. [DOI] [PubMed] [Google Scholar]
  • 23.Boaz M., Smetana S., Weinstein T., Matas Z., Gafter U., Iaina A., Knecht A., Weissgarten Y., Brunner D., Fainaru M., Green M.S. Secondary prevention with antioxidants of cardiovascular disease in end stage renal disease (SPACE): randomized placebo controlled trial. Lancet. 2000;356:1213–1218. doi: 10.1016/S0140-6736(00)02783-5. [DOI] [PubMed] [Google Scholar]
  • 24.Miller E.R., Appel L.J., Levander O.A., Levine D.M. The effect of antoxidant vitamin supplementation on traditional cardivascular risk factors. J. Cardiovasc. Risk. 1997;4:19–24. doi: 10.1097/00043798-199702000-00004. [DOI] [PubMed] [Google Scholar]
  • 25.Jialal I., Grundy S.M. Preservation of endogenous antioxidants in LDL by ascorbate but not probucol during oxidative modification. J. Clin. Invest. 1991;87:597–601. doi: 10.1172/JCI115035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Scaccini C., Cheisa G., Jialal I. A critical assessment of the effects of aminoguanidine and ascorbate on the oxidative modification of LDL; evidence for interference with some assays of lipoprotein oxidation by aminoguanidine. J. Lipid Res. 1994;35(6):1085–1092. [PubMed] [Google Scholar]
  • 27.Carr A.C., Frei B. Toward a new recommended dietary allowance for vitamin C based on antioxidant and health effects in humans. Am. J. Clin. Nutr. 1999;69:1086–1107. doi: 10.1093/ajcn/69.6.1086. [DOI] [PubMed] [Google Scholar]
  • 28.Fong J.C., Scott Kinlay, John Beltrame, Hiroyuki-Hikiti, Marco Wainstein, Dominik Behrendt, Jung Suh, Balz Frei, Mudge G.H., Selwyn A.P., Peter Ganz. Effect of Vitamin C and E on progression of transplant associated arteriosclerosis: a randomized trial. Lancet. 2002;359:1108–1113. doi: 10.1016/S0140-6736(02)08154-0. [DOI] [PubMed] [Google Scholar]

Articles from Indian Journal of Clinical Biochemistry are provided here courtesy of Springer

RESOURCES